| Trial ID: | L2883 |
| Source ID: | NCT02014740
|
| Associated Drug: |
Liraglutide
|
| Title: |
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
|
| Acronym: |
|
| Status: |
COMPLETED
|
| Study Results: |
YES
|
| Results: |
https://ClinicalTrials.gov/show/NCT02014740/results
|
| Conditions: |
Type 2 Diabetes|Overweight|Obesity
|
| Interventions: |
DRUG: Liraglutide|DRUG: Metformin
|
| Outcome Measures: |
Primary: Echocardiographic Epicardial Fat Thickness, Echocardiographic epicardial fat thickness is an non invasive, inexpensive, reproducible and direct measure of visceral fat. In fact, epicardial fat strongly reflects the intra-abdominal and intra-myocardial fat accumulation as measured by magnetic resonance imaging procedures., 6 months |
|
| Sponsor/Collaborators: |
Sponsor: University of Miami
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
PHASE4
|
| Enrollment: |
100
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
|
| Start Date: |
2014-03
|
| Completion Date: |
2017-03
|
| Results First Posted: |
2018-03-22
|
| Last Update Posted: |
2019-06-06
|
| Locations: |
University of Miami, Miami, Florida, 33136, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT02014740
|
